Cardiff RD - Search Results

1

Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice.

Davie SA, Maglione JE, Manner CK, Young D, Cardiff RD, MacLeod CL, Ellies LG. Davie SA, et al. Among authors: cardiff rd. Transgenic Res. 2007 Apr;16(2):193-201. doi: 10.1007/s11248-006-9056-9. Epub 2007 Jan 6. Transgenic Res. 2007. PMID: 17206489 Free PMC article.

2

Mammary tumor latency is increased in mice lacking the inducible nitric oxide synthase.

Ellies LG, Fishman M, Hardison J, Kleeman J, Maglione JE, Manner CK, Cardiff RD, MacLeod CL. Ellies LG, et al. Among authors: cardiff rd. Int J Cancer. 2003 Aug 10;106(1):1-7. doi: 10.1002/ijc.11178. Int J Cancer. 2003. PMID: 12794750 Free article.

3

Transgenic Polyoma middle-T mice model premalignant mammary disease.

Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL. Maglione JE, et al. Among authors: cardiff rd. Cancer Res. 2001 Nov 15;61(22):8298-305. Cancer Res. 2001. PMID: 11719463

4

Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes.

Maglione JE, McGoldrick ET, Young LJ, Namba R, Gregg JP, Liu L, Moghanaki D, Ellies LG, Borowsky AD, Cardiff RD, MacLeod CL. Maglione JE, et al. Among authors: cardiff rd. Mol Cancer Ther. 2004 Aug;3(8):941-53. Mol Cancer Ther. 2004. PMID: 15299077

5

Multipotent luminal mammary cancer stem cells model tumor heterogeneity.

Bao L, Cardiff RD, Steinbach P, Messer KS, Ellies LG. Bao L, et al. Among authors: cardiff rd. Breast Cancer Res. 2015 Oct 14;17(1):137. doi: 10.1186/s13058-015-0615-y. Breast Cancer Res. 2015. PMID: 26467658 Free PMC article.

6

Control of mammary tumor differentiation by SKI-606 (bosutinib).

Hebbard L, Cecena G, Golas J, Sawada J, Ellies LG, Charbono A, Williams R, Jimenez RE, Wankell M, Arndt KT, DeJoy SQ, Rollins RA, Diesl V, Follettie M, Chen L, Rosfjord E, Cardiff RD, Komatsu M, Boschelli F, Oshima RG. Hebbard L, et al. Among authors: cardiff rd. Oncogene. 2011 Jan 20;30(3):301-12. doi: 10.1038/onc.2010.412. Epub 2010 Sep 6. Oncogene. 2011. PMID: 20818417 Free PMC article.

7

Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ.

Namba R, Maglione JE, Young LJ, Borowsky AD, Cardiff RD, MacLeod CL, Gregg JP. Namba R, et al. Among authors: cardiff rd. Mol Cancer Res. 2004 Aug;2(8):453-63. Mol Cancer Res. 2004. PMID: 15328372

8

Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Maglione JE, McGoldrick ET, Liu S, Wurz GT, DeGregorio MW, Borowsky AD, MacLeod CL, Cardiff RD, Gregg JP. Namba R, et al. Among authors: cardiff rd. Breast Cancer Res. 2005;7(6):R881-9. doi: 10.1186/bcr1317. Epub 2005 Sep 13. Breast Cancer Res. 2005. PMID: 16280035 Free PMC article.

9

Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.

Namba R, Young LJ, Abbey CK, Kim L, Damonte P, Borowsky AD, Qi J, Tepper CG, MacLeod CL, Cardiff RD, Gregg JP. Namba R, et al. Among authors: cardiff rd. Clin Cancer Res. 2006 Apr 15;12(8):2613-21. doi: 10.1158/1078-0432.CCR-05-2170. Clin Cancer Res. 2006. PMID: 16638874

10

Heterogeneity of mammary lesions represent molecular differences.

Namba R, Maglione JE, Davis RR, Baron CA, Liu S, Carmack CE, Young LJ, Borowsky AD, Cardiff RD, Gregg JP. Namba R, et al. Among authors: cardiff rd. BMC Cancer. 2006 Dec 5;6:275. doi: 10.1186/1471-2407-6-275. BMC Cancer. 2006. PMID: 17147824 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page